Caressa Valdueza Highlights Best Practices for the Management of Common Adverse Events in Melanoma
Source: Onc Nursing News, December 2022
The common terminology criteria for adverse events (CATCAE) is a helpful tool for nurses when managing adverse events (AEs) in the treatment of melanoma with immunotherapies and targeted therapies, according to Caressa Valdueza, MSN, AGNP-BC, AOCNP.
Valdueza, a nurse practitioner at Weill Cornell Medicine, recently presented on managing such toxicities as part of an OncLive® State of the Science Summit™ that took place in November, 2022.In an interview with Oncology Nursing News®, Valdueza highlighted key takeaways from her presentation, noting promising new advances that are arising in the treatment paradigm and common AEs that nurses may observe with these treatments.
“There are good guidelines out there [such as] the CTCAE criteria and the National Comprehensive Cancer Network guidelines [that] provide robust instructions and details on how to manage treatment toxicities,” Valdueza said. “I want people in this arena of immunotherapy and targeted therapy to be aware that there are a lot of promising treatments for melanoma, it’s exciting.”